OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy
Shuai Guo, Wei Xiong, Jiaoyang Zhu, et al.
Biomaterials (2023) Vol. 302, pp. 122300-122300
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

MRI‐Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and Disulfidptosis
Shuai Guo, Zongheng Li, Ruilong Zhou, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 16

Different Valence States of Copper Ion Delivery against Triple-Negative Breast Cancer
Ting He, Qinan Tang, Qiaoju Ren, et al.
ACS Nano (2024)
Closed Access | Times Cited: 14

MOFs‐Based Magnetic Nanozyme to Boost Cascade ROS Accumulation for Augmented Tumor Ferroptosis
Ying Yuan, Bo Chen, Xingxing An, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 10

Cysteine Depletion-Initiated Redox Imbalance Evokes Ferroptosis and Pyroptosis for Enhanced Pancreatic Cancer Therapy
Hao Chen, Binbin Ding, Pan Zheng, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 4, pp. 1103-1111
Closed Access | Times Cited: 9

Magnetic Field-Optimized Paramagnetic Nanoprobe for T2/T1 Switchable Histopathological-Level MRI
Linlin Huo, Jie Zeng, Zhenyu Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12453-12467
Closed Access | Times Cited: 8

A Lysosome‐Targeted Magnetic Nanotorquer Mechanically Triggers Ferroptosis for Breast Cancer Treatment
Xueyan Wei, Yingze Li, Haotian Chen, et al.
Advanced Science (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 14

Nanoformulations of chemotherapeutic activators of the cGAS–STING pathway in tumor chemoimmunotherapy
Lingzhi Wang, Zhuo Yu, Jihong Zhang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103892-103892
Closed Access | Times Cited: 5

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 5

New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
Jiaqi Feng, Pengpeng Zhang, Dingli Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5

Application of nanoparticles with activating STING pathway function in tumor synergistic therapy
Yi Yang, Yaning Fang, Xin‐Yu Du, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114013-114013
Closed Access

Nano-Delivery of STING Agonists: Unraveling the Potential of Immunotherapy
Meng Zhang, Yating Ji, Mingxia Liu, et al.
Acta Biomaterialia (2025)
Closed Access

A nuclei bombing nano-system improves STING-activated cancer immunotherapy
Shuai Guo, Tianwang Guan, Rundong Tai, et al.
Nano Today (2025) Vol. 63, pp. 102749-102749
Closed Access

Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer
Haoqi Zhang, Yuanke Li, Helong Kang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Lactate/Cysteine Dual-Consuming Probiotic–Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy
Tian‐Qiu Xie, Xiao Yan, You‐Teng Qin, et al.
Nano Letters (2024) Vol. 24, Iss. 50, pp. 16132-16142
Closed Access | Times Cited: 4

Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers
Waqas Ahmad, Wasim Sajjad, Qinghao Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 18, pp. 4607-4629
Closed Access | Times Cited: 3

The Mutual Regulatory Role of Ferroptosis and Immunotherapy in Anti-tumor Therapy
Zhiguo Mao, Yilong Hu, Yinan Zhao, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 3

Hollow Mesoporous Calcium Peroxide Nanoparticles for Drug-Free Tumor Calcicoptosis Therapy
Huimin Zhou, Jing Yang, Zongheng Li, et al.
Acta Biomaterialia (2024) Vol. 185, pp. 456-466
Closed Access | Times Cited: 3

Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”
P. Xue, Huilan Zhuang, Sijie Shao, et al.
ACS Nano (2024) Vol. 18, Iss. 37, pp. 25795-25812
Closed Access | Times Cited: 3

Biologically Logic-Gated Trojan-Horse Strategy for Personalized Triple-Negative Breast Cancer Precise Therapy by Selective Ferroptosis and STING Pathway Provoking
Shuai Guo, Tianwang Guan, Yushen Ke, et al.
Biomaterials (2024) Vol. 315, pp. 122905-122905
Closed Access | Times Cited: 3

Recent Advances in Nanomaterial‐Mediated Cell Death for Cancer Therapy
Min Luo, Yuanmin Wang, Fukun Zhao, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3

Multifunctional Tumor-Targeting Carbon Dots for Tumor Microenvironment Activated Ferroptosis and Immunotherapy in Cancer Treatment
Yujun Bao, Guanghao Li, Siqi Li, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 8

Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes
Wenyan Hao, Nan Sun, Yueyue Fan, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 22, pp. 28193-28208
Closed Access | Times Cited: 2

Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy
Haohan Zhou, Yiyun Cheng, Quan Huang, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 921-943
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top